$MKSI

COLELLA GERALD G sold $6.7M of MKSI (indirect holdings)

COLELLA GERALD G sold 20,000 indirectly-held shares of MKS INC (MKSI) at an average of $333.40 ($330.38–$338.58, $6.67M total) across 7 trades on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · COLELLA GERALD G
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MKSI
Neutral
medium confidence
Mentioned
$MKSI
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MKSINeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity, but the disclosure alone does not provide new fundamentals, guidance, or regulatory/contract developments.

02

Market read

A $6.67M director sale is disclosed, but the 10b5-1 structure suggests limited informational content for valuation.

03

What to watch

Indirect ownership and multiple small trades across a price range can further dilute any inference about directionality.

Relevance 5/10Novelty 3/10Timing: Filed on 2026-05-28 for sales executed 2026-05-27.

Background

The article is an SEC Form 4 insider transaction disclosure for MKS Inc, showing a director’s open-market sale executed under a 10b5-1 plan.

Company-level read

Ticker impact

$MKSINeutralMedium confidence
Context

MKS Inc director Colella sold about 20,000 shares in open-market transactions under a 10b5-1 plan, totaling $6.67M.

Expected impact

Likely limited, short-lived impact; any move would be more sentiment-driven than fundamental.

Evidence & confidence

Form 4 shows an open-market sale by a director, explicitly under a pre-arranged 10b5-1 plan, which typically reduces signaling value versus discretionary sales.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst described.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect liquidity/portfolio management rather than bearish expectations.

Key entities

  • MKS Inc

    Subject of the Form 4 insider sale disclosure (MKSI).

  • COLELLA GERALD G

    Director who sold shares via open-market transactions under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TTMIHighAI 8/10

TTM Technologies Bets Big on AI, Defense Growth

TTM Technologies (TTMI) announced over $1 billion in investments, including a $650 million acquisition of MKS Inc.'s Ophir Optics unit and a $400 million expansion in China and Malaysia. The company reported strong Q3 earnings but saw a 29% share drop due to debt concerns. TTM's growth is driven by AI and defense demand, with shares up 77% over 12 months.

$MKSIHighAI 9/10

US defence group TTM Technologies to acquire Romanian optics factory as part of USD 650 million deal

TTM Technologies (TTMI) will acquire MKS Inc.'s Ophir Optics for $650M, including facilities in Romania and Israel. The deal, expected to close in Q2 2027, expands TTM's optical solutions for defense and industrial uses. TTM plans to finance the acquisition with cash, future cash flow, and borrowings. MKS aims to reduce debt and focus on core businesses.

$TTMIHighAI 9/10

TTM Technologies, Inc. has entered into a definitive agreement to acquire Ophir Optics business from MKS Inc. for $650 million.

TTM Technologies (TTMI) agreed to acquire Ophir Optics from MKS Inc. (MKSI) for $650M, payable in cash. The deal, expected to close in Q2 2027, is valued at 18x the target's 2026 EBITDA. TTM plans to fund the acquisition through cash, future cash flow, and borrowings. The transaction is expected to be immediately accretive to TTM's EBITDA margin and non-GAAP EPS.